H.C. Wainwright analyst Matthew Keller downgraded Sensei Biotherapeutics (NASDAQ: SNSE) from Buy to Neutral.The analyst comments "Despite encouraging early clinical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE